Article Name Hospital & Healthcare
Collaboration aims to improve accessibility and adoption of multi-cancer early detection solutions through a broader practitioner network
15th May, 2026
Collaboration aims to combine AI algorithms, protein datasets, and biological reagent platforms to support next-generation biomolecular design
15th May, 2026
Lancet-published Integral-1 results support nacubactam’s potential as a new option against drug-resistant Gram-negative infections
15th May, 2026
15-machine centre aims to address rising demand for renal care services
14th May, 2026
The transformation of modern diagnostics is being driven not only by artificial intelligence and data integration, but also by the rapid evolution of imaging technologies such as MRI and CT systems
14th May, 2026
Investment manager Michael Lamprecht highlights structural funding gaps, regulatory fragmentation, and the need for commercially viable antimicrobial resistance strategies
14th May, 2026
The company will present Proliv Rx, its FDA-approved physician-directed neuromodulation therapy for adults with major depressive disorder who have not responded adequately to antidepressant medication.
13th May, 2026
The recognition places Caracal’s nitrile examination glove within a vetted category of medical products meeting sustainability and safer chemical criteria for healthcare procurement.
13th May, 2026
Expansion of Duke-NUS’ Pathways to Medicine programme lets more aspiring doctors pursue diverse academic interests before joining medical school.
13th May, 2026
The FDA marketing authorisation establishes a new Class II device category for Aurie’s automated reusable no-touch intermittent urinary catheter system, with launch planned in Veterans Health Administration spinal cord injury hospitals later this year.
12th May, 2026
Mason has more than 25 years of experience in the medical device industry and more than a decade of executive-level healthcare leadership expertise
12th May, 2026
The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options.
11th May, 2026
The Tokyo office will support Japanese biopharmaceutical companies across the product lifecycle, combining market access, medical, marketing and strategic consulting capabilities under the leadership of Junji Yokokawa.
11th May, 2026
India Sebia, in collaboration with CAHO Diagnostic Division, is proud to announce the launch of the Autoimmunity Masterclass Series—a six-part academic webinar initiative aimed at advancing the understanding, early diagnosis, and clinical management of autoimmune diseases.
11th May, 2026
The redesigned website expands clinical evidence, workflow guidance and access pathways for the Vivio System, an FDA-cleared non-invasive device used to measure elevated left ventricular end-diastolic pressure in outpatient settings.
08th May, 2026
The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China.
08th May, 2026
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop.
08th May, 2026
Healthcare leaders at the Philips APAC Innovation Summit highlighted the need for stronger hospital information systems, wider digital health adoption, improved clinical workflows, and deeper collaboration across hospitals, technology providers, research bodies, and AI developers.
07th May, 2026
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer